IR News - Investors | Oncolys BioPharma Inc.

Contact
Disclaimer
Privacy Policy
Site Map

English

HOME
About
Pipeline
Investors
News & Event
Contact
Japanese

Home
About

Management Strategy

Business Model

CEO Message

Corporate Philosophy

Management

Board of Directors

Company Profile

Corporate History

Partnering

US Career
Pipeline

Outline of Our Pipeline

Telomelysin (OBP-301)

OBP-601 (Censavudine)

OBP-2011

OBP-702

OBP-801

TelomeScan (OBP-401 , OBP-1101)

Patent

Publications
Investors

IR Information

IR News

Our Philosophy

Our Pipeline Overview

Financial Statements

Presentation Materials

Stock Information

Stock Quotes

IR Inquiry

IR Disclaimer
News & Event

Top
> Investors
> IR News

IR News

Investors

Our Pipeline Overview

Financial Statements

Presentation Materials

Stock Information

pagetop

Oncolys BioPharma Inc.
All Rights Reserved. Oncolys BioPharma Inc.

HOME
About
Pipeline
Investors
News & Event

Contact
Disclaimer
Privacy Policy
Site Map